Navigation Links
Heska Enters Distribution Agreement with MWI Veterinary Supply

LOVELAND, Colo., Nov. 12, 2012 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider of veterinary diagnostic and specialty products, announced today a new distribution agreement with MWI Veterinary Supply.  MWI will inventory, market and promote the full line of Heska's veterinary products throughout the United States beginning January 2, 2013.  Certain products, such as the popular Vet/IV Infusion Pump, will be available through MWI immediately.

"We believe this partnership represents a significant opportunity," says Robert Grieve, Chairman and Chief Executive Officer of Heska Corporation.  "Improving the choices available for advanced diagnostic solutions will benefit both customers and the animal health industry as a whole, and improve business opportunities for both MWI and Heska."

"MWI is very pleased to offer our customers the additional solutions Heska's products provide.  We look forward to working with Heska as we continue our shared missions of serving veterinary professionals," said Jim Cleary, MWI President and Chief Executive Officer.

About Heska
Heska Corporation (NASDAQ: HSKA - News) sells advanced veterinary diagnostic and other specialty veterinary products.  Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines.  The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.  For further information on Heska and its products, visit the company's website at

About MWI
MWI is a leading distributor of animal health products across the United States and the United Kingdom. MWI sells both companion animal and production animal products including pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, supplies, pet food, capital equipment and technologies used by veterinarians and producers.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. There are uncertainties regarding Heska's ability to successfully commercialize new products; competition, including new products competitors may introduce in the future; uncertainties related to Heska's market estimates; uncertainties regarding Heska's ability to gain market share in an economic manner; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Quarterly Report on Form 10-Q for the quarter ended June 30, 2012.

SOURCE Heska Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Webcast Alert: Heska Announces Third Quarter 2012 Earnings Conference Call Webcast
2. Heska Corporation Announces Amendment To Its Odd-Lot Tender Offer
3. Heska to Present at B. Riley Investor Conference
4. Heska Announces Quarterly Dividend of $0.10 Per Share
5. Presentations at Leading Radiation Oncology Meeting Highlight CyberKnife Prostate Outcomes from Patients at More Than 40 Centers
6. Pharmalink Enters Manufacturing Agreement for Nefecon(R)
7. SAFC Enters South Korean BioPharma Market with CrystalGenomics Agreement
8. Surgical Equipment Market to 2018 - Increased Access to Ambulatory Surgical Centers to Drive Outpatient Surgery Volumes
9. Johnson & Johnson Announces Plans to Establish Innovation Centers
10. IBA Molecular Introduces Centers for Innovation
11. Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Womens Health Business to Meda
Post Your Comments:
(Date:11/26/2015)... , Nederland, November 26, 2015 ... Een nieuwe aanpak combineert immunotherapie met ... kanker. ) ...      (Photo: ) ... Leids Universitair Medisch Centrum (LUMC) ...
(Date:11/26/2015)... 26, 2015 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ... which demands kidney transplantation is expected to boost the market ... for organ transplantation. --> 3D bioprinting market ... to a new report by Grand View Research Inc. Rising ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
Breaking Medicine Technology:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... United States District Court of Connecticut on behalf of a home health care worker ... all current or former home health care workers employed by Humana, Inc., Humana at ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... across the country to celebrate their sobriety and show through pictures what a ... and after” photos this Thanksgiving with the hashtag #FacesOfGratitude on their Facebook, Twitter, ...
(Date:11/25/2015)... Florida (PRWEB) , ... November 25, 2015 , ... ... testing for physicians and athletic programs, launches new Wimbledon Athletics Facebook ... of testing young athletes for unsuspected cardiac abnormalities. About 2,000 people under the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is pleased ... moderate facial wrinkling. While many patients are aware of the benefits of Botox® in ... delivers to those suffering with discomfort, soreness, and pain as a result of Jaw ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw YMCA’s ... learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions ... 65 years, Brillianteen has been a treasured tradition for numerous families in the ...
Breaking Medicine News(10 mins):